Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Z A Massy

Showing results (1-10 of 84) with videos related to

Pageof 9
Sort By:
Nephrologie & Therapeutique|July 2, 2013
[Anomalous mineralization: how and why cardiovascular tissue can mineralize it?]Z-A Massy
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 10, 2000
Importance of homocysteine, lipoprotein (a) and non-classical cardiovascular risk factors (fibrinogen and advanced glycation end-products) for atherogenesis in uraemic patientsZ A Massy
Current Opinion in Urology|February 27, 2001
Cardiovascular risk factors in kidney transplantationZ A Massy
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 26, 1999
Reversal of hyperhomocyst(e)inaemia in chronic renal failure-is folic or folinic acid the answer?Z A Massy
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 1, 1996
Hyperhomocyst(e)inaemia in renal failure--what are the implications?Z A Massy
Transplantation|October 5, 2001
Hyperlipidemia and cardiovascular disease after organ transplantationZ A Massy
Nephrologie & Therapeutique|April 19, 2008
[Néphrologie & Thérapeutique: what is new in 2008?]Z A Massy, L Frimat
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 28, 2001
Statins: effects beyond cholesterol loweringZ A Massy, C Guijarro
Nephrologie|December 4, 2003
[Management of micro-inflammation in uremia]Z A Massy, G Choukroun
Presse Medicale (Paris, France : 1983)|June 6, 1992
[Apolipoprotein C-III in nephrology]Z A Massy, B Lacour
Pageof 9

Showing results (1-10 of 84) with videos related to

Sort By:
Pageof 9
Nephrologie & Therapeutique|July 2, 2013
[Anomalous mineralization: how and why cardiovascular tissue can mineralize it?]Z-A Massy
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 10, 2000
Importance of homocysteine, lipoprotein (a) and non-classical cardiovascular risk factors (fibrinogen and advanced glycation end-products) for atherogenesis in uraemic patientsZ A Massy
Current Opinion in Urology|February 27, 2001
Cardiovascular risk factors in kidney transplantationZ A Massy
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 26, 1999
Reversal of hyperhomocyst(e)inaemia in chronic renal failure-is folic or folinic acid the answer?Z A Massy
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 1, 1996
Hyperhomocyst(e)inaemia in renal failure--what are the implications?Z A Massy
Transplantation|October 5, 2001
Hyperlipidemia and cardiovascular disease after organ transplantationZ A Massy
Nephrologie & Therapeutique|April 19, 2008
[Néphrologie & Thérapeutique: what is new in 2008?]Z A Massy, L Frimat
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 28, 2001
Statins: effects beyond cholesterol loweringZ A Massy, C Guijarro
Nephrologie|December 4, 2003
[Management of micro-inflammation in uremia]Z A Massy, G Choukroun
Presse Medicale (Paris, France : 1983)|June 6, 1992
[Apolipoprotein C-III in nephrology]Z A Massy, B Lacour
Pageof 9